Rapid Communication| Volume 1, ISSUE 2, P131-136, 1988

Case report: McCune—Albright syndrome: Evidence for periodic estrogen secretion

      This paper is only available as a PDF. To read, Please Download here.


      A case of McCune—Albright Syndrome in a 3½-year-old girl is presented. Although there was clinical evidence of increased estrogen production, no steroid-dependent growth phase was apparent on her growth velocity chart. Complications of polyostotic fibrous dysplasia are discussed, and emphasis is placed on a multidisciplinary approach to patients with McCune—Albright Syndrome.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Pediatric and Adolescent Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Albright F
        • Butler AM
        • Hampton AC
        • et al.
        Syndrome characterized by ostitis fibrosa disseminata, areas of pigmentation, and endocrine dysfunction with precocious puberty in females.
        N Engl J Med. 1937; 216: 727-746
        • Foster CM
        • Ross JL
        • Shawkert
        • et al.
        Absence of pubertal gonadotropin secretion in girls with McCune-Albright Syndrome.
        J Clin Endocrinol Metab. 1984; 58: 1161-1165
        • Foster CM
        • Comite F
        • Pescovitz OH
        • et al.
        Variable response to a long-acting agonist of luteinizing hormone-releasing hormone in girls with McCune-Albright Syndrome.
        J Clin Endocrinol Metab. 1984; 59: 801-805
        • Feuillan PP
        • Foster CM
        • Pescovitz OH
        • et al.
        Treatment of precocious puberty in the McCune-Albright Syndrome with the aromatase inhibitor testolactone.
        N Engl J Med. 1986; 315: 1115-1119
        • Comite F
        • Shawker TH
        • Pescovitz OH
        Cyclical ovarian function resistant to treatment with an analogue of luteinizing hormone releasing hormone in McCune—Albright Syndrome.
        N Engl J Med. 1984; 311: 1032-1036
        • Lee PA
        • Van Dop C
        • Migeon CJ
        McCune—Albright Syndrome long term followup.
        JAMA. 1986; 256: 2980-2984
        • Pescovitz OH
        • Comite F
        • Hench K
        The NIH experience with precocious puberty:diagnostic subgroups and response to short term luteinizing hormone releasing hormone analogue therapy.
        J Pediatr. 1986; 108: 47-54
        • Nager GT
        • Kennedy DW
        • Kopstein E
        Fibrous dysplasia: a review of the disease and its manifestations in the temporal bone.
        Ann Otol Rhinol Laryngol (Suppl). 1982; 92: 1-52